Nidan Laboratories & Healthcare Ltd
₹ 23.9
-1.24%
05 Feb
- close price
About
Incorporated in 2000, Nidan Laboratories & Healthcare Ltd is in the business of providing various Healthcare and Diagnostics Services[1]
Key Points
- Market Cap ₹ 33.2 Cr.
- Current Price ₹ 23.9
- High / Low ₹ 41.2 / 23.0
- Stock P/E 17.3
- Book Value ₹ 48.4
- Dividend Yield 0.00 %
- ROCE 7.95 %
- ROE -0.03 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.49 times its book value
Cons
- The company has delivered a poor sales growth of 3.80% over past five years.
- Company has a low return on equity of 3.30% over last 3 years.
- Company's cost of borrowing seems high
- Working capital days have increased from 226 days to 366 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|
| 20.07 | 21.41 | 20.38 | 29.66 | 24.27 | 24.18 | 22.88 | |
| 12.23 | 13.78 | 11.49 | 20.25 | 17.47 | 17.74 | 17.17 | |
| Operating Profit | 7.84 | 7.63 | 8.89 | 9.41 | 6.80 | 6.44 | 5.71 |
| OPM % | 39.06% | 35.64% | 43.62% | 31.73% | 28.02% | 26.63% | 24.96% |
| 0.37 | 0.01 | 1.06 | 0.40 | 3.33 | -3.76 | -4.26 | |
| Interest | 4.75 | 3.74 | 3.46 | 2.66 | 2.22 | 2.18 | 2.08 |
| Depreciation | 3.24 | 3.19 | 3.18 | 2.63 | 3.10 | 2.87 | 2.93 |
| Profit before tax | 0.22 | 0.71 | 3.31 | 4.52 | 4.81 | -2.37 | -3.56 |
| Tax % | 0.00% | 0.00% | 30.21% | 41.15% | 26.40% | 36.29% | |
| 0.22 | 0.71 | 2.30 | 2.66 | 3.54 | -3.23 | -4.05 | |
| EPS in Rs | 0.22 | 0.72 | 2.32 | 1.91 | 2.55 | -2.32 | -2.92 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 6% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -22% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 3% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 9.90 | 9.90 | 9.90 | 13.90 | 13.90 | 13.90 | 13.90 |
| Reserves | 0.41 | 1.13 | 3.43 | 52.00 | 55.54 | 52.31 | 53.41 |
| 32.16 | 34.35 | 38.04 | 19.29 | 10.93 | 12.44 | 11.77 | |
| 0.58 | -0.17 | 2.37 | 3.29 | 4.03 | 3.90 | 4.37 | |
| Total Liabilities | 43.05 | 45.21 | 53.74 | 88.48 | 84.40 | 82.55 | 83.45 |
| 23.28 | 20.10 | 19.92 | 20.46 | 21.39 | 17.95 | 17.43 | |
| CWIP | 0.00 | 0.00 | 0.23 | 3.81 | 0.00 | 0.04 | 0.06 |
| Investments | 0.53 | 0.53 | 0.27 | 0.00 | 0.00 | 0.00 | 20.00 |
| 19.24 | 24.58 | 33.32 | 64.21 | 63.01 | 64.56 | 45.96 | |
| Total Assets | 43.05 | 45.21 | 53.74 | 88.48 | 84.40 | 82.55 | 83.45 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| 8.95 | 4.62 | 4.35 | 7.83 | 10.97 | -14.93 | |
| 1.00 | -0.01 | -3.22 | -35.74 | -0.29 | 9.84 | |
| -5.81 | -1.56 | -1.22 | 28.72 | -10.37 | -0.49 | |
| Net Cash Flow | 4.14 | 3.05 | -0.10 | 0.80 | 0.32 | -5.57 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Debtor Days | 102.03 | 92.57 | 97.25 | 65.96 | 90.69 | 7.85 |
| Inventory Days | 16.98 | 12.88 | 18.17 | 25.99 | ||
| Days Payable | 116.72 | -25.76 | 213.05 | 135.84 | ||
| Cash Conversion Cycle | 2.29 | 131.22 | -97.64 | -43.89 | 90.69 | 7.85 |
| Working Capital Days | 256.25 | 291.69 | 238.56 | 176.10 | 136.10 | 366.06 |
| ROCE % | 10.13% | 13.99% | 10.09% | 8.17% | 7.95% |
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
11 January 2025 - Nidan Laboratories And Healthcare Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
6 January 2025 - Nidan Laboratories And Healthcare Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter ended 31st December 2024
-
Reply to Clarification- Financial results
19 December 2024 - Exchange had sought clarification from Nidan Laboratories And Healthcare Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (LODR) Regulations, …
-
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
16 December 2024 - NIDAN LABORATORIES AND HEALTHCARE LIMITED has informed about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Outcome of Board Meeting
16 December 2024 - Nidan Laboratories And Healthcare Limited has informed regarding Board meeting held on December 16, 2024.
Business Overview:[1]
NLHL is a Healthcare Division of Nidan Group. It operates 35 diagnostic centers across Greater Mumbai under the Nidan Diagnostics brand. Services include CT scan, MRI, Ultrasound, 2D Echo, ECG, and more.